<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00623857</url>
  </required_header>
  <id_info>
    <org_study_id>WAO 93-442</org_study_id>
    <nct_id>NCT00623857</nct_id>
  </id_info>
  <brief_title>Micronutrients and Child Health Study</brief_title>
  <acronym>MACH</acronym>
  <official_title>Effects of Supplementation With Zinc and Other Micronutrients on the Health and Development of African Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wageningen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kilimanjaro Christian Medical Centre, Tanzania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Wageningen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine to what extent supplementation with zinc and other
      micronutrients are efficacious in preventing malaria in young Tanzanian children.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Zinc is essential for the functioning of the immune system. Supplementation trials in Asia,
      Latin America, the Pacific and developed countries have shown that increasing zinc intake has
      great potential to control common infections in children, but the response to supplementation
      may be different in Africa, where the primary environmental challenge to children's health is
      malaria. Simultaneous supplementation with other potentially limiting nutrients may be
      required to overcome a lack of response when zinc is given alone. The project aims at
      measuring effects of daily oral supplementation with zinc and other micronutrients, given
      either alone or in combination, on malaria incidence and nutritional status, and on
      indicators of immunity.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Febrile malaria episodes</measure>
    <time_frame>60 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Haematologic and urinary indicators of micronutrient status</measure>
    <time_frame>30 weeks after start of intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometric indices</measure>
    <time_frame>57 weeks after start of intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>T cell immune responses to in vitro stimulation with a crude Plasmodium falciparum lysate</measure>
    <time_frame>30 weeks after start of intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma immunoglobulin concentrations</measure>
    <time_frame>2 weeks after malaria episodes</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">612</enrollment>
  <condition>Malaria</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Zinc</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vitamins and minerals other than zinc</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vitamins plus zinc and other minerals</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo for all vitamins and minerals</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Zinc</intervention_name>
    <description>Daily oral supplementation with zinc, 10 mg, for an average of 60 weeks</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamins and minerals other than zinc</intervention_name>
    <description>Daily supplementation with vitamin A, vitamin B1, vitamin B2, niacin, vitamin B6, folic acid, vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K, iron, iodine, copper, selenium, magnesium and calcium; for an average of 60 weeks</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamins plus zinc and other minerals</intervention_name>
    <description>Daily oral supplementation with zinc, vitamin A, vitamin B1, vitamin B2, niacin, vitamin B6, folic acid, vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K, iron, iodine, copper, selenium, magnesium and calcium; for an average of 60 weeks</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Daily oral supplementation with placebo for vitamins and all minerals; for an average of 60 weeks</description>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 6-60 months

          -  Permanently residing in the study area

          -  Being moderately or mildly stunted (height-for-age z-score &lt;-1.5 SD)

          -  Informed consent from parents or guardians obtained

        Exclusion Criteria:

          -  Severe wasting (weight-for-height z-score &lt;-3 SD)

          -  Hemoglobin concentration &lt;70 g/L

          -  Axillary temperature ≥37.50 °C with malaria antigenemia

          -  Signs and symptoms at randomisation suggesting malaria, hepatitis, HIV/AIDS,
             tuberculosis, sickle cell disease or other severe condition

          -  Unable to produce a venous blood sample (&gt;1 mL)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>60 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hans Verhoef, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wageningen University, Cell Biology and Immunology Group</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raimos M Olomi, MD MMed MPH</last_name>
    <role>Study Chair</role>
    <affiliation>Kilimanjaro Christian Medical Centre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Huub FJ Savelkoul, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Wageningen University, Cell Biology and Immunology Group</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John F. Shao, MD</last_name>
    <role>Study Director</role>
    <affiliation>Kilimanjaro Christian Medical Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kilimanjaro Christian Medical Centre</name>
      <address>
        <city>Moshi</city>
        <country>Tanzania</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Tanzania</country>
  </location_countries>
  <results_reference>
    <citation>Imwong M, Woodrow CJ, Hendriksen IC, Veenemans J, Verhoef H, Faiz MA, Mohanty S, Mishra S, Mtove G, Gesase S, Seni A, Chhaganlal KD, Day NP, Dondorp AM, White NJ. Plasma concentration of parasite DNA as a measure of disease severity in falciparum malaria. J Infect Dis. 2015 Apr 1;211(7):1128-33. doi: 10.1093/infdis/jiu590. Epub 2014 Oct 24.</citation>
    <PMID>25344520</PMID>
  </results_reference>
  <results_reference>
    <citation>Pasricha SR, Atkinson SH, Armitage AE, Khandwala S, Veenemans J, Cox SE, Eddowes LA, Hayes T, Doherty CP, Demir AY, Tijhaar E, Verhoef H, Prentice AM, Drakesmith H. Expression of the iron hormone hepcidin distinguishes different types of anemia in African children. Sci Transl Med. 2014 May 7;6(235):235re3. doi: 10.1126/scitranslmed.3008249.</citation>
    <PMID>24807559</PMID>
  </results_reference>
  <results_reference>
    <citation>Hendriksen IC, White LJ, Veenemans J, Mtove G, Woodrow C, Amos B, Saiwaew S, Gesase S, Nadjm B, Silamut K, Joseph S, Chotivanich K, Day NP, von Seidlein L, Verhoef H, Reyburn H, White NJ, Dondorp AM. Defining falciparum-malaria-attributable severe febrile illness in moderate-to-high transmission settings on the basis of plasma PfHRP2 concentration. J Infect Dis. 2013 Jan 15;207(2):351-61. doi: 10.1093/infdis/jis675. Epub 2012 Nov 7.</citation>
    <PMID>23136222</PMID>
  </results_reference>
  <results_reference>
    <citation>Veenemans J, Schouten LR, Ottenhof MJ, Mank TG, Uges DR, Mbugi EV, Demir AY, Kraaijenhagen RJ, Savelkoul HF, Verhoef H. Effect of preventive supplementation with zinc and other micronutrients on non-malarial morbidity in Tanzanian pre-school children: a randomized trial. PLoS One. 2012;7(8):e41630. doi: 10.1371/journal.pone.0041630. Epub 2012 Aug 3.</citation>
    <PMID>22870238</PMID>
  </results_reference>
  <results_reference>
    <citation>Veenemans J, Milligan P, Prentice AM, Schouten LR, Inja N, van der Heijden AC, de Boer LC, Jansen EJ, Koopmans AE, Enthoven WT, Kraaijenhagen RJ, Demir AY, Uges DR, Mbugi EV, Savelkoul HF, Verhoef H. Effect of supplementation with zinc and other micronutrients on malaria in Tanzanian children: a randomised trial. PLoS Med. 2011 Nov;8(11):e1001125. doi: 10.1371/journal.pmed.1001125. Epub 2011 Nov 22.</citation>
    <PMID>22131908</PMID>
  </results_reference>
  <results_reference>
    <citation>Veenemans J, Jansen EJ, Baidjoe AY, Mbugi EV, Demir AY, Kraaijenhagen RJ, Savelkoul HF, Verhoef H. Effect of α(+)-thalassaemia on episodes of fever due to malaria and other causes: a community-based cohort study in Tanzania. Malar J. 2011 Sep 22;10:280. doi: 10.1186/1475-2875-10-280.</citation>
    <PMID>21939508</PMID>
  </results_reference>
  <results_reference>
    <citation>Veenemans J, Mank T, Ottenhof M, Baidjoe A, Mbugi EV, Demir AY, Wielders JP, Savelkoul HF, Verhoef H. Protection against diarrhea associated with Giardia intestinalis Is lost with multi-nutrient supplementation: a study in Tanzanian children. PLoS Negl Trop Dis. 2011 Jun;5(6):e1158. doi: 10.1371/journal.pntd.0001158. Epub 2011 Jun 7.</citation>
    <PMID>21666789</PMID>
  </results_reference>
  <results_reference>
    <citation>Mbugi EV, Meijerink M, Veenemans J, Jeurink PV, McCall M, Olomi RM, Shao JF, Chilongola JO, Verhoef H, Savelkoul HF. Effect of nutrient deficiencies on in vitro Th1 and Th2 cytokine response of peripheral blood mononuclear cells to Plasmodium falciparum infection. Malar J. 2010 Jun 14;9:162. doi: 10.1186/1475-2875-9-162.</citation>
    <PMID>20546583</PMID>
  </results_reference>
  <results_reference>
    <citation>Mbugi EV, Meijerink M, Veenemans J, Jeurink PV, McCall M, Olomi RM, Shao JF, Verhoef H, Savelkoul HF. Alterations in early cytokine-mediated immune responses to Plasmodium falciparum infection in Tanzanian children with mineral element deficiencies: a cross-sectional survey. Malar J. 2010 May 17;9:130. doi: 10.1186/1475-2875-9-130.</citation>
    <PMID>20470442</PMID>
  </results_reference>
  <results_reference>
    <citation>Veenemans J, Andang'o PE, Mbugi EV, Kraaijenhagen RJ, Mwaniki DL, Mockenhaupt FP, Roewer S, Olomi RM, Shao JF, van der Meer JW, Savelkoul HF, Verhoef H. Alpha+ -thalassemia protects against anemia associated with asymptomatic malaria: evidence from community-based surveys in Tanzania and Kenya. J Infect Dis. 2008 Aug 1;198(3):401-8. doi: 10.1086/589884.</citation>
    <PMID>18582194</PMID>
  </results_reference>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 14, 2008</study_first_submitted>
  <study_first_submitted_qc>February 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2008</study_first_posted>
  <last_update_submitted>November 14, 2014</last_update_submitted>
  <last_update_submitted_qc>November 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Micronutrients</keyword>
  <keyword>Zinc</keyword>
  <keyword>Vitamins</keyword>
  <keyword>Trace elements</keyword>
  <keyword>Minerals</keyword>
  <keyword>Vitamin A</keyword>
  <keyword>Vitamin B1</keyword>
  <keyword>Vitamin B2</keyword>
  <keyword>Niacin</keyword>
  <keyword>Vitamin B6</keyword>
  <keyword>Folic acid</keyword>
  <keyword>Vitamin B12</keyword>
  <keyword>Vitamin C</keyword>
  <keyword>Vitamin D</keyword>
  <keyword>Vitamin E</keyword>
  <keyword>Vitamin K</keyword>
  <keyword>Iron</keyword>
  <keyword>Iodine</keyword>
  <keyword>Copper</keyword>
  <keyword>Selenium</keyword>
  <keyword>Magnesium</keyword>
  <keyword>Calcium</keyword>
  <keyword>Malaria</keyword>
  <keyword>Immunity</keyword>
  <keyword>Anthropometry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malaria</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Vitamin A</mesh_term>
    <mesh_term>Vitamin K</mesh_term>
    <mesh_term>Niacin</mesh_term>
    <mesh_term>Vitamin B 12</mesh_term>
    <mesh_term>Hydroxocobalamin</mesh_term>
    <mesh_term>Vitamin B 6</mesh_term>
    <mesh_term>Pyridoxal</mesh_term>
    <mesh_term>Pyridoxine</mesh_term>
    <mesh_term>Thiamine</mesh_term>
    <mesh_term>Riboflavin</mesh_term>
    <mesh_term>Zinc</mesh_term>
    <mesh_term>Selenium</mesh_term>
    <mesh_term>Copper</mesh_term>
    <mesh_term>Micronutrients</mesh_term>
    <mesh_term>Trace Elements</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

